173 related articles for article (PubMed ID: 32004704)
1. Adherence of US Insurance Payer Policies to the American Society of Radiation Oncology Stereotactic Radiosurgery Model Policy.
Hassanzadeh C; Roach M; Rich K; Karraker P; Robinson C; Michalski J; Perkins S; Huang J; Tsien C; Abraham C
Pract Radiat Oncol; 2020; 10(4):e250-e254. PubMed ID: 32004704
[TBL] [Abstract][Full Text] [Related]
2. Differences in United States Insurance Payer Policies and American Society for Radiation Oncology's (ASTRO) Model Policy on Stereotactic Body Radiation Therapy (SBRT).
Roach MC; Thomas TO; Paravati AJ; Mahajan A
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):740-744. PubMed ID: 30677470
[TBL] [Abstract][Full Text] [Related]
3. Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model Policies.
Verma V; Ludmir EB; Mesko SM; Brooks ED; Augustyn A; Milano MT; Lin SH; Chang JY; Welsh JW
Pract Radiat Oncol; 2020; 10(5):324-329. PubMed ID: 31446147
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Health Insurance Policy on Radiation Oncology Physician SBRT/SABR Use Practices: A North American Survey.
Guo J; Kim H; Kalchman I; Dan TD; Zhan T; Werner-Wasik M
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):524-529. PubMed ID: 29280445
[TBL] [Abstract][Full Text] [Related]
5. Training Neurosurgery and Radiation Oncology Residents in Stereotactic Radiosurgery: Assessment Gathered from Participants in AANS and ASTRO Training Course.
Sheehan J; Suh JH; Kavanagh B; Xu Z; Ren L; Sheehan K; Lunsford LD
World Neurosurg; 2018 Jan; 109():e669-e675. PubMed ID: 29061451
[TBL] [Abstract][Full Text] [Related]
6. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS).
Seung SK; Larson DA; Galvin JM; Mehta MP; Potters L; Schultz CJ; Yajnik SV; Hartford AC; Rosenthal SA
Am J Clin Oncol; 2013 Jun; 36(3):310-5. PubMed ID: 23681017
[TBL] [Abstract][Full Text] [Related]
7. Inception of a national multidisciplinary registry for stereotactic radiosurgery.
Sheehan JP; Kavanagh BD; Asher A; Harbaugh RE
J Neurosurg; 2016 Jan; 124(1):155-62. PubMed ID: 26252466
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
[TBL] [Abstract][Full Text] [Related]
9. The radiation oncologist's perspective on stereotactic radiosurgery.
Regine W
Technol Cancer Res Treat; 2002 Feb; 1(1):43-9. PubMed ID: 12614176
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the ventral intermediate nucleus for medically refractory tremor: A cost-analysis of stereotactic radiosurgery versus deep brain stimulation.
McClelland S; Jaboin JJ
Radiother Oncol; 2017 Oct; 125(1):136-139. PubMed ID: 28818305
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based methodology for obtaining commercial insurance coverage of stereotactic radiosurgery for intractable epilepsy.
McClelland S; Verma V
Rep Pract Oncol Radiother; 2020; 25(6):899-901. PubMed ID: 32982597
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery of the brain: a review of common indications.
Gilbo P; Zhang I; Knisely J
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S14. PubMed ID: 28917252
[TBL] [Abstract][Full Text] [Related]
13. Impact of the American Tax Payer Relief Act on stereotactic radiosurgery utilization in the United States.
McClelland S; Degnin C; Chen Y; Watson GA; Jaboin JJ
J Neurooncol; 2019 Oct; 145(1):159-165. PubMed ID: 31485922
[TBL] [Abstract][Full Text] [Related]
14. Assessment of costs in open surgery and stereotactic radiosurgery for vestibular schwannomas.
Abou-Al-Shaar H; Azab MA; Karsy M; Guan J; Alzhrani G; Gozal YM; Jensen RL; Couldwell WT
J Neurosurg; 2018 Oct; 131(2):561-568. PubMed ID: 30485235
[TBL] [Abstract][Full Text] [Related]
15. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.
Park HS; Wang EH; Rutter CE; Corso CD; Chiang VL; Yu JB
J Neurosurg; 2016 Apr; 124(4):1018-24. PubMed ID: 26473783
[TBL] [Abstract][Full Text] [Related]
16. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
17. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
18. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
19. [Functional stereotactic radiosurgery: Indications and perspectives].
Dupic G; Biau J; Lemaire JJ; Ortholan C; Clavelou P; Lapeyre M; Colin P; Khalil T
Cancer Radiother; 2020 Apr; 24(2):166-173. PubMed ID: 32220562
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
